Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Human Genetics|July 11, 2002
Allele-specific PCR amplification due to sequence identity between a PCR primer and an amplicon: is direct sequencing so reliable?Shiro Ikegawa, Akihiko Mabuchi, Masako Ogawa, et al.
International Journal of Surgery Case Reports|July 19, 2021
A case report of gallbladder cancer and pancreas cystic neoplasm associated with pancreaticobiliary maljunctionKazuhito Sato, Eisaku Ito, Yukiyoshi Masaki, et al.
Digestive Diseases and Sciences|April 15, 2006
Omeprazole treatment ameliorates oxyntic atrophy induced by DMP-777Masako Ogawa, Sachiyo Nomura, Bruce D Car, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 25, 2005
Altered metaplastic response of waved-2 EGF receptor mutant mice to acute oxyntic atrophyMasako Ogawa, Sachiyo Nomura, Andrea Varro, et al.
Autoimmune Diseases|November 14, 2013
DNA damage in rheumatoid arthritis: an age-dependent increase in the lipid peroxidation-derived DNA adduct, heptanone-etheno-2'-deoxycytidineMasako Ogawa, Tomonari Matsuda, Atsushi Ogata, et al.
Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry|February 1, 2003
Oligodeoxynucleotide-modified capillary for electrophoretic separation of single-stranded DNAs with a single-base differenceTakahisa Anada, Masako Ogawa, Hisashi Yokomizo, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 14, 2005
Alterations in gastric mucosal lineages induced by acute oxyntic atrophy in wild-type and gastrin-deficient miceSachiyo Nomura, Hirokazu Yamaguchi, Masako Ogawa, et al.
Surgery Today|July 2, 2025
Association of visceral fat with unresectable/recurrent gastric cancer patients following chemotherapy: a propensity score-matched analysisRyohei Nishiguchi, Takeshi Shimakawa, Shinichi Asaka, et al.
Digestive Diseases and Sciences|June 10, 2009
Alterations in gastric mucosal lineages before or after acute oxyntic atrophy in gastrin receptor and H2 histamine receptor-deficient miceSusumu Aikou, Yasushi Fukushima, Masako Ogawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 16, 2011
[Evaluation of efficacy and safety of first-line docetaxel/cisplatin/5-FU combined therapy for advanced esophageal cancer]Mayumi Minowa, Yoshihiro Kinoshita, Shinobu Hasebe, et al.
Pageof 2